Helping Molecular Diagnostics and Precision Medicine Companies Enter and Grow in Colombia.
Strategic market access, stakeholder engagement and commercial intelligence for healthcare innovators seeking growth opportunities in Latin America.
Why Colombia
A strategic entry point to Latin America.
Colombia combines a sophisticated healthcare ecosystem, a growing precision medicine agenda and a regulatory environment that rewards well-prepared international entrants.
Regional Gateway
A natural hub to expand into the Andean region and broader Latin America from a single base of operations.
Precision Medicine Momentum
Accelerating adoption of genomics, oncology biomarkers and advanced molecular diagnostics across leading institutions.
Engaged Stakeholders
Active payers, KOLs, reference laboratories and academic centers open to international partnerships.
What we do
Boutique advisory for precision healthcare.
Focused engagements designed for molecular diagnostics, oncology and precision medicine leaders evaluating Colombia and Latin America.
Market Entry Feasibility Assessment
Independent diagnosis of demand, competition, reimbursement and regulatory pathways to validate the opportunity in Colombia.
Clinical Adoption Strategy
Stakeholder mapping, KOL engagement and clinical positioning to accelerate uptake among reference centers and laboratories.
In-Country Business Development Representation
Senior, on-the-ground representation to open conversations, qualify partners and advance commercial discussions on your behalf.
About the founder
Helping Global Precision Medicine Companies Succeed in Colombia
Diego Rodríguez founded Nexa Precision Advisory after years of commercial leadership in molecular diagnostics and precision oncology. His experience spans market access, physician engagement, commercial strategy, and healthcare navigation within the Colombian healthcare system.
Having worked directly with leading genomic technologies, he understands the scientific, commercial, and regulatory challenges international healthcare companies face when entering emerging markets.
Nexa Precision Advisory was created to bridge that gap, providing strategic guidance that reduces uncertainty and accelerates successful market entry through local expertise, trusted clinical relationships, and evidence-based commercial execution.
Commercial Strategy
Market Entry & Business Development
Precision Medicine
Molecular Diagnostics & Oncology
Healthcare Network
Clinical & Institutional Relationships
Colombia Market Expertise
Market Access & Local Execution
Why work with us
Deep Regional Expertise
On-the-ground knowledge of payers, regulators and KOLs across Colombia and Latin America.
Proven Market Access Frameworks
Methodologies refined across diagnostics, oncology and precision medicine launches.
End-to-End Execution
From access strategy to commercial rollout — senior partners stay engaged through delivery.
Get in touch
Schedule a Discovery Call.
Tell us about your therapy, diagnostic or platform. We'll share how Nexa can support your entry and growth in Colombia and Latin America.